Latest News in the pharma Industry

Research & Development

X4 Pharma initiates clinical study of X4P-001 in combination with Opdivo

X4 Pharma initiates clinical study of X4P-001 in combination with Opdivo

28 Jan 2017

Combination studied as treatment for patients with advanced clear cell renal cell carcinoma.

Read more 
Non-opiate painkiller, AnestaGel, found superior in preclinical tests

Non-opiate painkiller, AnestaGel, found superior in preclinical tests

26 Jan 2017

AnestaGel uses a novel approach to delivering sustained-released analgesics into the target tissue via the Matrix, which is a tunable, biocompatible, and pH neutral platform.

Read more 
Axim Biotech enters IBS clinical trial for CanChew CBD chewing gum

Axim Biotech enters IBS clinical trial for CanChew CBD chewing gum

26 Jan 2017

Clinical trial is the first of its kind to treat IBS symptoms by cannabinoid-containing chewing gum.

Read more 
Clinerion introduces new services for market access

Clinerion introduces new services for market access

25 Jan 2017

Disease prevalence can be monitored with a precision never before possible.

Read more 
Zymeworks opens state-of-the-art lab facility

Zymeworks opens state-of-the-art lab facility

25 Jan 2017

Provides the company with increased control over discovery research, antibody generation, medicinal chemistry and bioconjugation for generating antibody drug conjugates.

Read more 
FDA approves IND for Vectura's VR647

FDA approves IND for Vectura's VR647

24 Jan 2017

VR647 is a drug/device combination, using the AKITA JET smart nebuliser, for the delivery of nebulised budesonide.

Read more 
Enteris and Sanofi to develop oral therapeutic for type 2 diabetes

Enteris and Sanofi to develop oral therapeutic for type 2 diabetes

25 Jan 2017

Feasibility study to examine three different oral formulations engineered with Enteris’ Peptelligence platform.

Read more 
Enamine expands collaboration with Europe’s largest biopharmaceutical company

Enamine expands collaboration with Europe’s largest biopharmaceutical company

23 Jan 2017

Extends multi-year agreement in drug discovery with focus on cardiovascular and central nervous system disorders, immunology, infectious diseases and oncology.

Read more 
Molecule shows ability to thwart pathogens’ genetic resistance to antibiotic

Molecule shows ability to thwart pathogens’ genetic resistance to antibiotic

23 Jan 2017

The molecule, which is a PPMO, will likely be ready for testing in humans in about 3 years.

Read more 
Concert Pharmaceuticals receives FDA orphan drug designation for CTP-656 for the treatment of CF

Concert Pharmaceuticals receives FDA orphan drug designation for CTP-656 for the treatment of CF

22 Jan 2017

Topline results from the Phase II trial are expected by year-end 2017.

Read more 
EMA validates Gilead’s MAA for investigational chronic Hep C therapy

EMA validates Gilead’s MAA for investigational chronic Hep C therapy

22 Jan 2017

Sofosbuvir/Velpatasvir/Voxilaprevir cranted an accelerated assessment by the EMA.

Read more 
FDA approves Allergan's Rhofade cream, 1% for persistent facial erythema

FDA approves Allergan's Rhofade cream, 1% for persistent facial erythema

19 Jan 2017

Once-daily treatment reduces persistent facial erythema associated with rosacea through 12 hours.

Read more